Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2026-01-31 @ 5:45 AM
Study NCT ID:
NCT03709550
Status:
WITHDRAWN
Last Update Posted:
2022-10-05
First Post:
2018-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Castration Levels of Testosterone | View |
| None | Castration-Resistant Prostate Carcinoma | View |
| None | Metastatic Prostate Carcinoma in the Soft Tissue | View |
| None | Prostate Carcinoma Metastatic in the Bone | View |
| None | PSA Level Greater Than or Equal to Two | View |
| None | PSA Progression | View |
| None | Stage IV Prostate Cancer AJCC v8 | View |
| None | Stage IVA Prostate Cancer AJCC v8 | View |
| None | Stage IVB Prostate Cancer AJCC v8 | View |
Keywords: